Aspen Pharmacare had discussed destroying its stockpile of life-saving cancer drugs in order to drive up prices by 4000%, according to a report by The Times of London.
This comes after the JSE-listed pharmaceutical company bought the rights to five cancer drugs from GlaxoSmithKline.
The company [Aspen Pharmacare] would have enjoyed a monopoly in the marketplace and was no doubt tempted to use its newly gained power to exploit its customers and reap fabulous returns for its shareholders...— Rob Worthington-Smith, FarSightFirms
FarSightFirms rates the maturity of a company’s leadership based on how it responds to material non-financial issues (material to the medium- to long-term financial sustainability of the company).
It did extensive research into Aspen Pharmacare.
The drug maker also failed to disclose its 2016 €5.2-million Italian competition authority fine for price gouging.
Is Aspen Pharmacare morally bankrupt?
The Money Show’s Bruce Whitfield interviewed Worthington-Smith.
Although Aspen Pharmacare Chairperson Kuseni Dlamini was scheduled to talk to Whitfield he decided not to come on the show when he heard what the topic of conversation was.
Listen to the interview in the audio below (and/or scroll down for quotes from it).
They [Aspen Pharmacare] make fluffy statements about caring for customers…— Rob Worthington-Smith, FarSightFirms
You can’t be cheating the marketplace.— Rob Worthington-Smith, FarSightFirms
There isn’t evidence of a moral code.— Rob Worthington-Smith, FarSightFirms
It’s important that companies stand for something.— Rob Worthington-Smith, FarSightFirms
I’d love to think Aspen Pharmacare has a communication problem [instead of an ethics one].— Rob Worthington-Smith, FarSightFirms
Enter your email address in the form below to receive a newsletter containing the most-read articles of the week from Bruce Whitfield’s The Money Show every Friday morning in your inbox.
Recommendedby NEWSROOM AI
The South African billionaire has responded to reports placing him at the centre of an alleged tax evasion scheme.
President Ramaphosa is invoking his inner Mandela for political ends, says Political Economy Analyst Daniel Silke.
You could say elections are being disrupted.
He's been implicated in an elaborate tax-dodging scheme, says amaBhungane’s Craig McKune.
Trofin fund manager Claudius Rostoll on why he believes these three companies are the best investments on the JSE right now.
Aspen Group released results saying the international business delivered 49% of gross revenue.
The new Home Affairs upgrades to the system include printing parents details at the back of the child's passport.
The UK’s Food Standards Agency issued an advisory, claiming that Rolkem failed to confirm that their ingredients were safe to eat.
The South African ad is still trending around the world. Bruce Whitfield interviews branding and advertising expert Andy Rice.
Bruce Whitfield interviews La Grange about her and Madiba's attitude to money (hopes and fears, successes and failures, etc.)
The Panorama, Welgelegen and Plattekloof Neighbourhood Watch has identified a new house break-in trend.